Pharmaceutical Biotechnology

A set of molecular biology techniques used to combine genetic material from different sources, creating sequences that would not otherwise be found in nature. In pharmaceutical biotechnology, it enables the production of human proteins in microbial or mammalian host cells by inserting the corresponding gene into an expression vector.

Laboratory-made proteins that mimic the immune system's ability to target specific antigens. They are produced from a single B-cell clone and are identical in structure, providing high specificity and reproducibility for therapeutic use against cancer, autoimmune diseases, and infectious agents.

A class of biopharmaceuticals that use synthetic messenger RNA to instruct cells to produce specific proteins, triggering an immune response or replacing a deficient protein. The mRNA is typically encapsulated in lipid nanoparticles for delivery into cells.

Chimeric Antigen Receptor T-cell therapy is a form of immunotherapy where a patient's T cells are genetically modified ex vivo to express a synthetic receptor that recognizes a specific tumor antigen, then reinfused into the patient to target and kill cancer cells.

The design, development, and optimization of manufacturing processes for biopharmaceuticals, including upstream processes (cell culture, fermentation) and downstream processes (purification, formulation). It ensures consistent product quality, yield, and scalability.

A therapeutic approach that introduces, alters, or replaces genetic material within a patient's cells to treat or prevent disease. Delivery is typically achieved using viral vectors (adeno-associated virus, lentivirus) or non-viral methods such as lipid nanoparticles.

Biologic products that are highly similar to an already-approved reference biologic with no clinically meaningful differences in safety, purity, or potency. Unlike generic small-molecule drugs, biosimilars require extensive comparative analytical, nonclinical, and clinical studies due to the structural complexity of biologics.

The study of how biologic drugs are absorbed, distributed, metabolized, and eliminated in the body. Unlike small molecules, biologics are typically administered by injection, have large molecular weights, undergo target-mediated drug disposition, and are catabolized by proteolytic degradation rather than hepatic metabolism.

A genome editing technology that uses a guide RNA to direct the Cas9 nuclease to a specific DNA sequence, where it creates a double-strand break. The cell's repair mechanisms can then be harnessed to knock out a gene, correct a mutation, or insert new genetic material.

A class of targeted cancer therapeutics that combine a monoclonal antibody linked to a cytotoxic drug (payload) via a chemical linker. The antibody delivers the potent chemotherapy agent directly to cancer cells expressing the target antigen, minimizing systemic toxicity.